Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2,226Revenue (TTM) $M92.0Net Margin (%)8.5Altman Z-Score4.0
Enterprise Value $M2,326EPS (TTM) $0.3Operating Margin %38.7Piotroski F-Score5
P/E(ttm)357Beneish M-Score-2.4Pre-tax Margin (%)7.1Higher ROA y-yN
Price/Book6.610-y EBITDA Growth Rate %--Quick Ratio0.6Cash flow > EarningsY
Price/Sales25.55-y EBITDA Growth Rate %--Current Ratio0.6Lower Leverage y-yY
Price/Free Cash Flow66.9y-y EBITDA Growth Rate %51.8ROA % (ttm)1.4Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)2.4Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M20.9ROIC % (ttm)7.3Gross Margin Increase y-yY

Gurus Latest Trades with LGND

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
LGNDJoel Greenblatt 2016-09-30 Reduce-0.05%$99.64 - $138.53
($117.7)
$ 106.51-10%Reduce -46.81%38,231
LGNDJoel Greenblatt 2016-06-30 Add0.07%$107.09 - $130.37
($118.77)
$ 106.51-10%Add 229.35%71,870
LGNDKen Fisher 2016-06-30 Add$107.09 - $130.37
($118.77)
$ 106.51-10%Add 2.56%72,390
LGNDJoel Greenblatt 2016-03-31 Buy 0.03%$85.79 - $108.42
($97.41)
$ 106.519%New holding21,822
LGNDKen Fisher 2015-12-31 Reduce$85.69 - $111.85
($99.19)
$ 106.517%Reduce -0.14%70,583
LGNDKen Fisher 2015-09-30 Reduce$82.1 - $111.25
($97.26)
$ 106.5110%Reduce -12.31%70,683
LGNDKen Fisher 2015-06-30 Reduce$75.67 - $100.9
($87.3)
$ 106.5122%Reduce -1.59%80,608
LGNDJoel Greenblatt 2015-03-31 Sold Out -0.0016%$51.54 - $77.11
($61.42)
$ 106.5173%Sold Out0
LGNDJoel Greenblatt 2014-12-31 Reduce-0.26%$42.36 - $57.96
($52.25)
$ 106.51104%Reduce -99.32%3,766
LGNDKen Fisher 2014-12-31 Add0.01%$42.36 - $57.96
($52.23)
$ 106.51104%Add 132.31%81,908
LGNDJoel Greenblatt 2014-09-30 Add0.23%$46.99 - $64.52
($53.04)
$ 106.51101%Add 894.83%552,053
LGNDJoel Greenblatt 2014-06-30 Buy 0.04%$59.74 - $70.19
($65.09)
$ 106.5164%New holding55,492
LGNDKen Fisher 2014-06-30 Buy $59.74 - $70.19
($65.09)
$ 106.5164%New holding36,908
LGNDJoel Greenblatt 2014-03-31 Sold Out -0.02%$51.52 - $79.58
($66.37)
$ 106.5160%Sold Out0
LGNDJoel Greenblatt 2013-12-31 Add0.01%$44.86 - $57.95
($52.33)
$ 106.51104%Add 124.95%13,803
LGNDJoel Greenblatt 2013-09-30 Buy 0.01%$38.69 - $49.66
($45.21)
$ 106.51136%New holding6,136
LGNDGeorge Soros 2011-09-30 Sold Out -0.0017%$10.89 - $15.95
($13.18)
$ 106.51708%Sold Out0
LGNDGeorge Soros 2011-06-30 Buy $9.56 - $12.02
($10.55)
$ 106.51910%New holding10,000
LGNDGeorge Soros 2009-12-31 Sold Out $9.96 - $14.16
($12.14)
$ 106.51777%Sold Out0
LGNDGeorge Soros 2009-09-30 Buy $13.74 - $18.9
($16.16)
$ 106.51559%New holding4,483
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

LGND is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


LGND: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Aryeh JasonDirector 2016-11-25Sell18,479$107.310.41view
Aryeh JasonDirector 2016-11-18Sell6,330$105.282.35view
HIGGINS JOHN LCEO 2016-09-22Sell3,000$117.34-8.17view
KOZARICH JOHN WDirector 2016-09-07Sell1,000$115-6.3view
KOZARICH JOHN WDirector 2016-09-01Sell1,666$105.42.23view
FOEHR MATTHEW WPresident and COO 2016-08-05Sell12,500$122.14-11.78view
Berkman Charles SVP, Gen. Counsel & Secretary 2016-08-05Sell22,067$123.16-12.51view
KOZARICH JOHN WDirector 2016-08-01Sell1,000$137.57-21.68view
KOZARICH JOHN WDirector 2016-07-01Sell1,000$121.4-11.24view
KOZARICH JOHN WDirector 2016-06-01Sell1,000$117.42-8.24view

Quarterly/Annual Reports about LGND:

News about LGND:

Articles On GuruFocus.com
Gurus Invest in Top Biotechnology Stocks Jun 20 2016 
RS Investment Increases Holdings in Ulta Salon, Noble Energy and Fortune Brands Dec 23 2015 
Dan Loeb Sees Opportunity in Latest Activist Target Baxter International Aug 06 2015 
Dan Loeb Sees Opportunity in Latest Activist Target Baxter International Aug 06 2015 
Ligand Pharmaceuticals - Severe competitive threat to key royalty program and “going concern” ri Jun 19 2014 
5 Hot Stocks to Consider Now Mar 30 2012 
Ligand Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 05 2010 
Ligand Pharmaceuticals Inc. Reports Operating Results (10-Q) May 05 2010 
Ligand Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 09 2009 
Ligand Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 04 2009 

More From Other Websites
Ligand Pharmaceuticals Inc. (LGND): Hedge Fund Sentiment Unchanged Dec 05 2016
INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Ligand... Dec 01 2016
Lifshitz & Miller Law Firm Announces Investigation of Adeptus Health Inc., Avid Technology, Inc.,... Dec 01 2016
INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Ligand Pharmaceuticals Inc. of a... Nov 30 2016
INVESTOR NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Ligand... Nov 29 2016
Robbins Arroyo LLP: Ligand Pharmaceuticals Incorporated (LGND) Misled Shareholders According to a... Nov 29 2016
Lawsuit for Investors in Ligand Pharmaceuticals Inc. (NASDAQ:LGND) over alleged Violations of... Nov 29 2016
IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against... Nov 29 2016
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against... Nov 29 2016
SHAREHOLDER NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Ligand... Nov 27 2016
SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who... Nov 27 2016
INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Ligand... Nov 25 2016
LGND SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a... Nov 25 2016
LIGAND PHARMACEUTICALS INC Financials Nov 23 2016
SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Ligand... Nov 23 2016
LIGAND PHARMACEUTICALS INVESTOR ALERT: Hagens Berman Alerts Ligand Pharmaceuticals Investors to... Nov 23 2016
LGND LOSS ALERT: Rosen Law Firm Reminds Ligand Pharmaceuticals Incorporated Investors of Important... Nov 22 2016
Ligand's Partner Retrophin Provides New Data on Sparsentan Nov 22 2016
IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Ligand... Nov 21 2016
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Ligand Pharmaceuticals Inc. of... Nov 21 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)